MDC Stock Overview
Mediclinic International plc, together with its subsidiaries, operates private hospitals. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Mediclinic International plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£5.01 |
| 52 Week High | UK£5.14 |
| 52 Week Low | UK£3.86 |
| Beta | 0.42 |
| 11 Month Change | 0.44% |
| 3 Month Change | 0.56% |
| 1 Year Change | 25.38% |
| 33 Year Change | 68.12% |
| 5 Year Change | -14.94% |
| Change since IPO | -43.77% |
Recent News & Updates
Recent updates
Here's Why We Think Mediclinic International (LON:MDC) Might Deserve Your Attention Today
Jul 26
Estimating The Intrinsic Value Of Mediclinic International plc (LON:MDC)
Jul 12Here's Why Mediclinic International (LON:MDC) Can Manage Its Debt Responsibly
Jun 28Are Investors Undervaluing Mediclinic International plc (LON:MDC) By 50%?
Apr 08Is Mediclinic International (LON:MDC) Using Too Much Debt?
Mar 09Mediclinic International (LON:MDC) Takes On Some Risk With Its Use Of Debt
Nov 20Is There An Opportunity With Mediclinic International plc's (LON:MDC) 25% Undervaluation?
Sep 08Is Mediclinic International (LON:MDC) Using Too Much Debt?
Jun 21Does This Valuation Of Mediclinic International plc (LON:MDC) Imply Investors Are Overpaying?
May 26If You Had Bought Mediclinic International's (LON:MDC) Shares Five Years Ago You Would Be Down 63%
Mar 17What Kind Of Shareholders Hold The Majority In Mediclinic International plc's (LON:MDC) Shares?
Feb 26Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability
Feb 11Have Mediclinic International plc (LON:MDC) Insiders Been Selling Their Stock?
Jan 27
Estimating The Fair Value Of Mediclinic International plc (LON:MDC)
Jan 18These 4 Measures Indicate That Mediclinic International (LON:MDC) Is Using Debt Extensively
Jan 01A Look At Mediclinic International's (LON:MDC) Share Price Returns
Dec 17Our View On Mediclinic International's (LON:MDC) CEO Pay
Dec 02Shareholder Returns
| MDC | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0.1% | -3.9% | -0.3% |
| 1Y | 25.4% | -24.2% | 6.1% |
Return vs Industry: MDC exceeded the UK Healthcare industry which returned 5.3% over the past year.
Return vs Market: MDC exceeded the UK Market which returned -2.5% over the past year.
Price Volatility
| MDC volatility | |
|---|---|
| MDC Average Weekly Movement | 0.5% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: MDC has not had significant price volatility in the past 3 months.
Volatility Over Time: MDC's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 33,683 | Ronnie van der Merwe | www.mediclinic.com |
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom.
Mediclinic International plc Fundamentals Summary
| MDC fundamental statistics | |
|---|---|
| Market cap | UK£3.69b |
| Earnings (TTM) | UK£169.00m |
| Revenue (TTM) | UK£3.38b |
21.9x
P/E Ratio1.1x
P/S RatioIs MDC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDC income statement (TTM) | |
|---|---|
| Revenue | UK£3.38b |
| Cost of Revenue | UK£2.66b |
| Gross Profit | UK£728.00m |
| Other Expenses | UK£559.00m |
| Earnings | UK£169.00m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 21.52% |
| Net Profit Margin | 5.00% |
| Debt/Equity Ratio | 54.1% |
How did MDC perform over the long term?
See historical performance and comparison